Related Experiment Videos
Interaction of chlorpromazine with DNA
N Motohashi1, K Kamata, R Meyer
1Meiji College of Pharmacy, Tokyo, Japan.
Anticancer Research
|November 1, 1990
Summary
Chlorpromazine hydrochloride (CPZ) interacts with DNA nucleotides, forming non-Newtonian systems. This anticancer agent shows potential through its interaction with DNA, altering viscosity and molecular structure.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Chlorpromazine hydrochloride (CPZ) is investigated as a potential anticancer agent.
- Understanding the interaction between CPZ and DNA is crucial for its therapeutic development.
Purpose of the Study:
- To elucidate the mechanism of interaction between CPZ and DNA at a molecular level.
- To investigate the structural and physical changes induced by CPZ binding to DNA and its components.
Main Methods:
- High-performance liquid chromatography (HPLC) was used to analyze CPZ-DNA and CPZ-nucleotide interactions.
- Viscosity measurements were employed to assess changes in system properties under shear stress.
- Raman spectroscopy was utilized to detect molecular structural alterations, specifically focusing on the phosphate group vibrations.
Main Results:
- HPLC analysis suggested the formation of CPZ-DNA and CPZ-nucleotide complexes, with CPZ interacting with DNA nucleotides.
- Viscosity studies revealed increased shear stress in CPZ-DNA and CPZ-nucleotide systems compared to DNA or nucleotides alone, indicating non-Newtonian properties.
- Raman spectroscopy showed significant spectral changes at 982 cm-1 in the CPZ-dGMP system, attributed to alterations in the symmetric P-O stretching vibration of the PO4(2-) group.
Conclusions:
- CPZ interacts with DNA nucleotides, not nucleosides.
- The interaction leads to the formation of systems with non-Newtonian properties and altered viscosity.
- CPZ binding induces measurable structural changes in DNA components, providing insights into its potential anticancer mechanism.